angiotensinogen and Squamous-Cell-Carcinoma-of-Head-and-Neck

angiotensinogen has been researched along with Squamous-Cell-Carcinoma-of-Head-and-Neck* in 1 studies

Other Studies

1 other study(ies) available for angiotensinogen and Squamous-Cell-Carcinoma-of-Head-and-Neck

ArticleYear
Cancer Stem Cells in Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma Express Components of the Renin-Angiotensin System.
    Cells, 2021, 01-27, Volume: 10, Issue:2

    We investigated the expression of components of the renin-angiotensin system (RAS) by cancer stem cell (CSC) subpopulations in metastatic head and neck cutaneous squamous cell carcinoma (mHNcSCC). Immunohistochemical staining demonstrated expression of prorenin receptor (PRR), angiotensin-converting enzyme (ACE), and angiotensin II receptor 2 (AT

    Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme 2; Angiotensinogen; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Microvessels; Middle Aged; Neoplasm Metastasis; Neoplastic Stem Cells; Prorenin Receptor; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Cell Surface; Renin; Renin-Angiotensin System; Squamous Cell Carcinoma of Head and Neck; Stromal Cells

2021